Otto Analytics
PDF
Mercury Systems is a structurally advantaged, hard-to-replicate supplier of secure, trusted mission-processing electronics into a multi-year defense modernization supercycle — a real infrastructure position with a $1.6B record backlog and ITAR/trusted-foundry barriers competitors can't cheaply cross. The Ballhaus turnaround is genuine and the macro tailwind is durable. But the stock has already run +121% in a year, trades above every analyst target on margins still half of management's own goal, and is pricing a fully-recovered Mercury that doesn't yet exist.
Visionary and Macro Man define a strong thesis spine. Mercury sits at the intersection of US defense modernization, NATO rearmament to 3%+ GDP, EW/radar/missile-defense ("Golden Dome") demand, and the mandated domestic trusted-microelectronics ecosystem — a structural regulatory moat. Operator confirms the moat is real: 10–30yr program design-in lock-in, cleared/TS-SCI manufacturing, $1.6B record backlog, 1.48x book-to-bill. The turnaround shows in the numbers — adj. EBITDA margin 15.3% vs ~11% a year ago, FCF positive after years of pain. The Electronic Warfare TAM alone is projected to roughly double to ~$64.66B by 2031 (14.9% CAGR), and Mercury is a picks-and-shovels supplier to that spend.
Skeptic and Quant carry the warning. The recovery is incomplete and priced as if complete: 15.3% adj. EBITDA margin is still ~half the mid-20s target; TTM FCF already re-decelerated to $73.5M from $119M; Q3 FCF was actually -$2M with ~$25M pulled forward from Q4. Valuation is extreme — ~80x EV/EBITDA (GAAP), ~107x forward non-GAAP P/E, ~7x P/S on a still-GAAP-loss business, 12% above consensus target, with Goldman at a Sell, $68. Thesis killer: a $20M+ EAC charge resurrection on a ramping fixed-price program would crack both the margin narrative and the multiple.
The bull case wins on the business and loses on the entry. I can refute the Skeptic on durability — the moat and backlog are real, the turnaround is structurally sound, and the macro tailwind is bipartisan and multi-year. What I cannot refute is the valuation math. At ~80x EV/EBITDA on margins still half of target, 12% above consensus, with Goldman at a Sell ($68) and zero insider buying into a 121% rally, the price embeds flawless execution. An unrefuted valuation bear case caps conviction. I want to own Mercury — not at $114. That's why it's Accumulate/Watch, not Buy.
| Metric | Value | Note |
|---|---|---|
| Price | $113.91 | +121% 1yr; above $101.50 consensus |
| Revenue (TTM) | ~$967M | +8.95% YoY; +11.5% organic Q3 |
| Backlog | ~$1.6B record | Book-to-bill 1.48x |
| Adj. EBITDA margin | 15.3% (Q3) | vs ~11% yr-ago; target mid-20s |
| Gross Margin | 28.7% TTM | vs FY21 peak 41.7%; peers 35–38% |
| GAAP EPS (TTM) | -$0.23 | Still loss-making |
| FCF (TTM) | $73.5M | down from $119M FY25; Q3 -$2M |
| EV/EBITDA | ~80x GAAP | ~50x adj; vs A&D peers ~15–28x |
| Fwd P/E (non-GAAP) | ~107x | Prices full recovery |
| P/S | ~7x | vs CW ~4x, HEI ~6x |
| Rule of 40 | ~17 | Fail |
| Net Debt | ~$322M | ~2.2x adj. EBITDA |
| Short Interest | ~8% | Rising |
Per Risk Manager: 2% recommended, 3.5% hard cap, staged/DCA entry (8–12 weeks) — not lump-sum here. Overlaps existing defense/A&D (ITA-correlated); size down if you already hold the theme. Worst case: margin relapse + EAC charge re-tests $45–68, a ~50–55% drawdown (historical max drawdown ~72%, 2020 peak → 2024 trough). Cleanest expression: small starter only on a pullback into the $90–100 structural support zone, build on thesis confirmation (margin march toward 20%, clean FCF, book-to-bill >1).
This report is produced and published by Otto Analytics, LLC ("the Company") and is provided for informational and educational purposes only. It is general in nature, does not constitute investment, financial, legal, or tax advice, and does not take into account the individual circumstances, objectives, financial situation, or risk tolerance of any reader.
No advisory relationship. Nothing in this report creates an investment-advisory, fiduciary, or other client relationship between you and the Company. The Company is not a registered investment adviser or broker-dealer and does not provide personalized investment advice or recommendations.
Not an offer or solicitation. This report is not an offer to sell, or a solicitation of an offer to buy, any security, and should not be relied upon in connection with any investment decision.
AI-generated content. This analysis is generated in whole or in part by an automated artificial-intelligence system based on a stated analytical objective. It may contain errors, omissions, or inaccuracies, and has not necessarily been independently verified by a human analyst. Data may be drawn from third-party sources believed to be reliable but not guaranteed to be accurate or current.
Risk of loss. All investing involves risk, including the possible loss of principal. Past performance is not indicative of future results. Forward-looking statements are inherently uncertain and should not be relied upon as predictions of actual future events.
Conflicts / positions. The Company, its owners, or affiliates may hold positions in the securities discussed herein. Any such positions are disclosed in the report where applicable.
Do your own due diligence. You are solely responsible for your own investment decisions and for executing your own trades. You should consult a licensed financial professional, attorney, and/or tax advisor before making any investment decision.
By accessing this report, you acknowledge and agree to the foregoing. This disclaimer is governed by the laws of the State of Oregon.